Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/06/2002EP1254139A1 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
11/06/2002EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002EP1254137A1 PYRIDO 2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
11/06/2002EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002EP1254135A2 Aminoheterocyclylamides as pesticides and antiparasitic agents
11/06/2002EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002EP1254133A2 Indol-3-yl derivatives
11/06/2002EP1254132A1 Food product and process
11/06/2002EP1254131A1 Extraction of flavonoids
11/06/2002EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002EP1254121A1 Preparation of sulfonamides
11/06/2002EP1254120A1 Use of pyrimidine endothelin antagonists in companion animals
11/06/2002EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
11/06/2002EP1254112A2 Ocular hypotensive lipids
11/06/2002EP1254111A1 Novel vitamin d analogues
11/06/2002EP1254108A1 Gamma-secretase inhibitors
11/06/2002EP1254106A1 Calcilytic compounds
11/06/2002EP1254104A1 Quaternary ammonium compounds and their use as anti-tussive agent
11/06/2002EP1254102A1 Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
11/06/2002EP1254101A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity
11/06/2002EP1253966A2 Substances and agents for positively influencing collagen
11/06/2002EP1253945A2 Ace inhibitor-vasopressin antagonist combinations
11/06/2002EP1253944A2 Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent
11/06/2002EP1253943A2 Photodynamic therapy for treating conditions of the eye
11/06/2002EP1253926A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
11/06/2002EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002EP1253923A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
11/06/2002EP1253922A2 Statin-type bone growth stimulators
11/06/2002EP1253921A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/06/2002EP1253920A1 An essential constituent and method of use for maintaining hair coloration or reversing hair discoloration
11/06/2002EP1253919A1 Method and compositions for treating an inflammatory disease
11/06/2002EP1253918A2 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
11/06/2002EP1253917A2 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
11/06/2002EP1253916A1 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/06/2002EP1253915A1 Method for treating stress with a precursor of serotonin
11/06/2002EP1253914A2 Use of gangliosides and other substances for modulating sphingolipid-cholesterol microdomains
11/06/2002EP1253909A2 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias
11/06/2002EP1253908A2 Pharmaceutical composition for pulmonary delivery
11/06/2002EP1253906A1 Cosmetic preparations containing waltheria indica extracts
11/06/2002EP1253853A1 Method for classifying and treating physiologic brain imbalances using quantitative eeg
11/06/2002EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002EP1124788A4 Bis(haloethyl)aminobenzene derivatives
11/06/2002EP1112076A4 Polymeric compounds and methods of formulating same
11/06/2002EP1109818B1 Phosphoepoxides, method for making same and uses
11/06/2002EP1107731B1 Synthetic tear fluid
11/06/2002EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002EP1037622A4 Taurine derivatives usable in the treatment of ophthalmic disorders
11/06/2002EP1031570B1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
11/06/2002EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
11/06/2002EP1000038B1 Novel pyrimidin derivatives
11/06/2002EP0993459B1 Compounds useful for inhibition of farnesyl protein transferase
11/06/2002EP0981349B1 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumours and cns diseases
11/06/2002EP0981327B1 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
11/06/2002EP0971923B1 Synthesis of acyclic nucleoside derivatives
11/06/2002EP0951287B1 Oral composition comprising 5-aminosalicyclic acid
11/06/2002EP0940401B1 2-carbonylthiazole derivatives and use of the same
11/06/2002EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002EP0923576B1 4-aminoethoxy-indolone derivatives as dopamine d2 agonists
11/06/2002EP0920421B1 Isoxazoline derivatives useful as antimicrobials
11/06/2002EP0912559B1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
11/06/2002EP0910355B1 Traitement and prevention of adverse effects of reactive oxygen species
11/06/2002EP0906338B1 Glucagon-like peptide-2 analogs
11/06/2002EP0906288B1 New compounds
11/06/2002EP0901488B1 2,4-diaminopyrimidine derivatives
11/06/2002EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002EP0898566B1 Substituted benzylamines and their use for the treatment of depression
11/06/2002EP0888386B1 Stable factor viii/ von willebrand factor complex
11/06/2002EP0871619B1 Phenyl thiazole derivatives with anti herpes virus properties
11/06/2002EP0865297B1 Vaccine compositions for intranasal administration comprising chitosan and use thereof
11/06/2002EP0837682B1 Therapeutic use of 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonic acid and its salts
11/06/2002EP0825861B1 High-dose chromic tripicolinate for the treatment of type ii diabetes
11/06/2002EP0812192B1 Benzothiopyranoindazoles antitumor agents
11/06/2002EP0800528B1 Peptide and peptide analog protease inhibitors
11/06/2002EP0784476B1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and optionally a vitamin b 12 compound
11/06/2002EP0781280B1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
11/06/2002EP0758335B1 Preparation of a camptothecin derivative by intramolecular cyclisation
11/06/2002EP0717618B1 Stabilized tablet formulation
11/06/2002EP0639970B2 Contraception method using competitive progesterone antagonists and novel compounds useful therein
11/06/2002EP0623134B1 Metal complexes of water soluble texaphyrins
11/06/2002CN1378594A T-cell receptor gamma alternate reading frame protein (TARP) and uses thereof
11/06/2002CN1378554A Novel fusidic acid derivatives
11/06/2002CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002CN1378550A Partial or full A1 agonists-N6 heterocyclic 5' thio substituted adenosine devivatives
11/06/2002CN1378547A 5-(2-substituted-5-heterocyclylsulphenylpyrid-3-yl)-dihydropyrazolo [4,3-d] pyrimidin 7-ones as phosphodiesterase inhibitors
11/06/2002CN1378546A Antibiotic sultam and sultone drived oxazolidiones
11/06/2002CN1378545A Substituted pyrroles as antiproliferative agents for treatment of cancer
11/06/2002CN1378544A Substituted azoles compounds
11/06/2002CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002CN1378542A FAB I inhibitors
11/06/2002CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002CN1378540A New piperazine and piperidine compounds
11/06/2002CN1378539A Thiocarbamic acid derivatives
1 ... 5659 5660 5661 5662 5663 5664 5665 5666 5667 5668 5669 5670 5671 5672 5673 5674 5675 5676 5677 5678 5679 ... 7860